Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 157

    1.

    The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis.

    Koc F, Kavuncu S, Kansu T, Acaroglu G, Firat E.

    Br J Ophthalmol. 2005 Nov;89(11):1442-4.PMID: 16234449 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    False negative apraclonidine test in two patients with Horner syndrome.

    Kawasaki A, Borruat FX.

    Klin Monbl Augenheilkd. 2008 May;225(5):520-2.PMID: 18454417 [PubMed - indexed for MEDLINE]Related articles

    3.

    Efficacy of apraclonidine 0.5% in the diagnosis of Horner syndrome in pediatric patients under low or high illumination.

    Chen PL, Hsiao CH, Chen JT, Lu DW, Chen WY.

    Am J Ophthalmol. 2006 Sep;142(3):469-74.PMID: 16935593 [PubMed - indexed for MEDLINE]Related articles

    4.

    Topical apraclonidine in the diagnosis of suspected Horner syndrome.

    Freedman KA, Brown SM.

    J Neuroophthalmol. 2005 Jun;25(2):83-5.PMID: 15937427 [PubMed - indexed for MEDLINE]Related articles

    5.

    [Usefulness of apraclonidine in the diagnosis of Horner syndrome]

    Pérez-Iñigo MA, González I, Fernández FJ, Díaz S, Ferrer C, Alias E, Honrubia FM.

    Arch Soc Esp Oftalmol. 2009 Feb;84(2):105-8. Spanish. PMID: 19253181 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    The use of apraclonidine in the diagnosis of horner syndrome in pediatric patients.

    Bacal DA, Levy SR.

    Arch Ophthalmol. 2004 Feb;122(2):276-9. No abstract available. PMID: 14769608 [PubMed - indexed for MEDLINE]Related articles

    7.

    Adverse effects of apraclonidine used in the diagnosis of Horner syndrome in infants.

    Watts P, Satterfield D, Lim MK.

    J AAPOS. 2007 Jun;11(3):282-3.PMID: 17572343 [PubMed - indexed for MEDLINE]Related articles

    8.

    Comparing efficacies of 0.5% apraclonidine with 4% cocaine in the diagnosis of horner syndrome in pediatric patients.

    Chen PL, Chen JT, Lu DW, Chen YC, Hsiao CH.

    J Ocul Pharmacol Ther. 2006 Jun;22(3):182-7.PMID: 16808679 [PubMed - indexed for MEDLINE]Related articles

    9.

    The utility of 0.5% apraclonidine in the diagnosis of horner syndrome.

    Brown SM, Aouchiche R, Freedman KA.

    Arch Ophthalmol. 2003 Aug;121(8):1201-3. No abstract available. PMID: 12912704 [PubMed - indexed for MEDLINE]Related articles

    10.

    Congenital Horner's syndrome and the usefulness of the apraclonidine test in its diagnosis.

    Mirzai H, Baser EF.

    Indian J Ophthalmol. 2006 Sep;54(3):197-9.PMID: 16921219 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effect of 0.5% apraclonidine on ptosis in Horner syndrome.

    Garibaldi DC, Hindman HB, Grant MP, Iliff NT, Merbs SL.

    Ophthal Plast Reconstr Surg. 2006 Jan-Feb;22(1):53-5.PMID: 16418668 [PubMed - indexed for MEDLINE]Related articles

    12.

    The utility of 0.5% apraclonidine in the diagnosis of horner syndrome.

    Brown SM.

    Arch Ophthalmol. 2005 Apr;123(4):578; author reply 578. No abstract available. PMID: 15824244 [PubMed - indexed for MEDLINE]Related articles

    13.

    Topical apraclonidine testing discloses pupillary sympathetic denervation in diabetic patients.

    Koc F, Kansu T, Kavuncu S, Firat E.

    J Neuroophthalmol. 2006 Mar;26(1):25-9.PMID: 16518162 [PubMed - indexed for MEDLINE]Related articles

    14.

    Pupillary autonomic neuropathy simulating partial Horner syndrome in diabetes mellitus and its reversal with control of blood glucose.

    Pishdad GR, Pishdad P, Pishdad R.

    J Neuroophthalmol. 2008 Sep;28(3):241-2. No abstract available. PMID: 18769297 [PubMed - indexed for MEDLINE]Related articles

    15.

    False-negative apraclonidine testing in acute Horner syndrome.

    Dewan MA, Harrison AR, Lee MS.

    Can J Ophthalmol. 2009 Feb;44(1):109-10. No abstract available. PMID: 19169332 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Possible effect of systemic sympathicolytic drugs on apraclonidine test.

    Martín-Moro JG, Botín DM, Muñoz-Negrete FJ.

    Can J Ophthalmol. 2009 Aug;44(4):463; author reply 463-4. No abstract available. PMID: 19606173 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Positive apraclonidine test within two weeks of onset of Horner syndrome caused by carotid artery dissection.

    Bohnsack BL, Parker JW.

    J Neuroophthalmol. 2008 Sep;28(3):235-6. No abstract available. PMID: 18769292 [PubMed - indexed for MEDLINE]Related articles

    18.

    Ocular effects of apraclonidine in Horner syndrome.

    Morales J, Brown SM, Abdul-Rahim AS, Crosson CE.

    Arch Ophthalmol. 2000 Jul;118(7):951-4.PMID: 10900109 [PubMed - indexed for MEDLINE]Related articles

    19.

    Are we ready to replace cocaine with apraclonidine in the pharmacologic diagnosis of Horner syndrome?

    Kardon R.

    J Neuroophthalmol. 2005 Jun;25(2):69-70. No abstract available. PMID: 15937425 [PubMed - indexed for MEDLINE]Related articles

    20.

    Horner's syndrome, Pseudo-Horner's syndrome, and simple anisocoria.

    Martin TJ.

    Curr Neurol Neurosci Rep. 2007 Sep;7(5):397-406. Review.PMID: 17764630 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data